UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 56

Sortiert nach

Pharmacotoxicology of clinically-relevant concentrations of obeticholic acid in an organotypic human hepatocyte system

Toxicology in vitro, 2017-03, Vol.39, p.93-103

2017

Volltextzugriff (PDF)

Hypercoagulation and thrombophilia in liver disease

Journal of thrombosis and haemostasis, 2008-01, Vol.6 (1), p.2-9

2008

Volltextzugriff (PDF)

O82 CLINICAL UTILITY OF NON-INVASIVE MEASURES OF FIBROSIS IN THE AMBULATORY POPULATION

Journal of hepatology, 2014-04, Vol.60 (1), p.S33-S34

2014

Volltextzugriff (PDF)

G14 : Systemic inflammatory response syndrome (SIRS) is a major determinant of treatment response to terlipressin for hepatorenal syndrome type 1 (HRS-1)

Journal of hepatology, 2015-04, Vol.62, p.S235-S236

2015

Volltextzugriff (PDF)

P0198 : Percentage change in serum creatinine (SCr) is a sensitive indicator of therapeutic response to terlipressin in hepatorenal syndrome type 1 (HRS-1)

Journal of hepatology, 2015-04, Vol.62, p.S379-S380

2015

Volltextzugriff (PDF)

Regenerate: A Phase 3, Double-Blind, Randomized, Placebo-Controlled Multicenter Study of Obeticholic Acid Therapy for Nonalcoholic Steatohepatitis

Journal of hepatology, 2016, Vol.64 (2), p.S294-S295

2016

Volltextzugriff (PDF)

The diagnostic accuracy of vibration controlled transient elastography for cirrhosis in subjects with nonalcoholic fatty liver disease

Journal of hepatology, 2017, Vol.66 (1), p.S426-S426

2017

Volltextzugriff (PDF)

The point of care 13C-Methacetin Breath Test predicts risk of long-term liver-related death or transplantation in patients with chronic liver disease: a sensitive, noninvasive monitoring tool in clinical hepatology

Journal of hepatology, 2017, Vol.66 (1), p.S668-S669

2017

Volltextzugriff (PDF)

LP10 : Efficacy and safety of vitamin E for nonalcoholic steatohepatitis: Combined analysis of three controlled trials

Journal of hepatology, 2015-04, Vol.62, p.S268-S268

2015

Volltextzugriff (PDF)

P1074 : No evidence for platelet hyperactivity in patients with non-alcoholic fatty liver disease

Journal of hepatology, 2015-04, Vol.62, p.S751-S752

2015

Volltextzugriff (PDF)

P1076 : Non-alcoholic fatty liver disease is not associated with plasma hypercoagulability

Journal of hepatology, 2015-04, Vol.62, p.S752-S753

2015

Volltextzugriff (PDF)

An Innovative app focused on patients and caregivers significantly decreases avoidable and HE-related readmissions in cirrhotic patients

Journal of hepatology, 2017, Vol.66 (1), p.S377-S378

2017

Volltextzugriff (PDF)

A Systematic Literature Review of the Epidemiology and Economic Burden Associated with Non-Alcoholic Steatohepatitis

Journal of hepatology, 2016, Vol.64 (2), p.S475-S475

2016

Volltextzugriff (PDF)

Predictors of Improvement in NAFLD Activity Score on Placebo: A Secondary Analysis of the Flint Trial

Journal of hepatology, 2016, Vol.64 (2), p.S191-S191

2016

Volltextzugriff (PDF)

Evaluation of Effects of Concomitant Medications for Non-Alcoholic Steatohepatitis and Associated Comorbidities on Histological Improvements with Obeticholic Acid

Journal of hepatology, 2016, Vol.64 (2), p.S487-S488

2016

Volltextzugriff (PDF)

Comprehensive NAFLD diagnosis based on a noninvasive metabolomic approach in a liquid biopsy

Journal of hepatology, 2017, Vol.66 (1), p.S670-S671

2017

Volltextzugriff (PDF)

613 VALIDATION OF A DEFINITION AND GRADING SYSTEM FOR ACUTE ON CHRONIC LIVER FAILURE

Journal of hepatology, 2012-04, Vol.56, p.S243-S243

2012

Volltextzugriff (PDF)

P297 VITAMIN E ALTERS INTESTINAL MICROBIOME THROUGH DIFFERENTIAL CHANGES IN MUCOSAL AND FECAL MICROBIOTA IN MOUSE MODEL OF NONALCOHOLIC FATTY LIVER DISEASE (NALFD)

Journal of hepatology, 2014-04, Vol.60 (1), p.S164-S164

2014

Volltextzugriff (PDF)

O044 : Distinct fecal and plasma bile acid metabolome of microbial origin characterizes human nonalcoholic fatty liver disease (NAFLD)

Journal of hepatology, 2015-04, Vol.62, p.S210-S211

2015

Volltextzugriff (PDF)

P0372 : Gideon: A retrospective analysis of prognostic factors for survival

Journal of hepatology, 2015-04, Vol.62, p.S451-S452

2015

Volltextzugriff (PDF)

191 EIGHT QUESTIONS OF THE PATIENT-REPORTED SICKNESS IMPACT PROFILE CAN EFFECTIVELY SCREEN FOR MINIMAL HEPATIC ENCEPHALOPATHY

Journal of hepatology, 2013-04, Vol.58, p.S84-S84

2013

Volltextzugriff (PDF)

148 PROTON PUMP INHIBITOR USE IS ASSOCIATED WITH THE DEVELOPMENT OF A BROAD RANGE OF INFECTIONS IN CIRRHOSIS

Journal of hepatology, 2010, Vol.52, p.S66-S66

2010

Volltextzugriff (PDF)

792 48 WEEKS OF PEGINTERFERON alfa-2a/RIBAVIRIN IMPROVES SVR24 AND DECREASES RELAPSE ACROSS HCV GENOTYPE 2/3 PATIENT SUBGROUPS NOT ACHIEVING A RAPID VIROLOGICAL RESPONSE: N-CORE STUDY

Journal of hepatology, 2013-04, Vol.58, p.S323-S323

2013

Volltextzugriff (PDF)

109 GIDEON (GLOBAL INVESTIGATION OF THERAPEUTIC DECISIONS IN HEPATOCELLULAR CARCINOMA AND OF ITS TREATMENT WITH SORAFENIB) SECOND INTERIM ANALYSIS: CLINICAL FINDINGS IN CHILD-PUGH B SCORE SUBGROUPS

Journal of hepatology, 2012-04, Vol.56, p.S48-S49

2012

Volltextzugriff (PDF)

150 SEVERITY OF CHRONIC COGNITIVE IMPAIRMENT IN CIRRHOSIS INCREASES WITH NUMBER OF EPISODES OF OVERT HEPATIC ENCEPHALOPATHY

Journal of hepatology, 2010, Vol.52, p.S66-S67

2010

Volltextzugriff (PDF)

1 – 25 von 56

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(55)
Mit Volltextzugriff
(54)

Publikationsform

Artikel
(56)

Sprache

Englisch
(56)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Gastroenterology And Hepatology
(29)
Humans
(5)
Life Sciences & Biomedicine
(5)
Science & Technology
(5)
Male
(3)
Peritonitis - Etiology
(3)
Biological And Medical Sciences
(2)
Drug Resistance, Microbial
(2)
Medical Sciences
(2)
Middle Aged
(2)
Peritoneal Dialysis, Continuous Ambulatory - Adverse Effects
(2)
Peritonitis - Microbiology
(2)
Physiology
(2)
Vancomycin - Pharmacology
(2)
Absorcion
(1)
Absorcion Digestiva
(1)
Absorption
(1)
Absorption Digestive
(1)
Acids
(1)
Aged
(1)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pharmacotoxicology of clinically-relevant concentrations of obeticholic acid in an organotypic human hepatocyte system

Hypercoagulation and thrombophilia in liver disease

O82 CLINICAL UTILITY OF NON-INVASIVE MEASURES OF FIBROSIS IN THE AMBULATORY POPULATION

G14 : Systemic inflammatory response syndrome (SIRS) is a major determinant of treatment response to terlipressin for hepatorenal syndrome type 1 (HRS-1)

P0198 : Percentage change in serum creatinine (SCr) is a sensitive indicator of therapeutic response to terlipressin in hepatorenal syndrome type 1 (HRS-1)

Regenerate: A Phase 3, Double-Blind, Randomized, Placebo-Controlled Multicenter Study of Obeticholic Acid Therapy for Nonalcoholic Steatohepatitis

The diagnostic accuracy of vibration controlled transient elastography for cirrhosis in subjects with nonalcoholic fatty liver disease

The point of care 13C-Methacetin Breath Test predicts risk of long-term liver-related death or transplantation in patients with chronic liver disease: a sensitive, noninvasive monitoring tool in clinical hepatology

LP10 : Efficacy and safety of vitamin E for nonalcoholic steatohepatitis: Combined analysis of three controlled trials

P1074 : No evidence for platelet hyperactivity in patients with non-alcoholic fatty liver disease

P1076 : Non-alcoholic fatty liver disease is not associated with plasma hypercoagulability

An Innovative app focused on patients and caregivers significantly decreases avoidable and HE-related readmissions in cirrhotic patients

A Systematic Literature Review of the Epidemiology and Economic Burden Associated with Non-Alcoholic Steatohepatitis

Predictors of Improvement in NAFLD Activity Score on Placebo: A Secondary Analysis of the Flint Trial

Evaluation of Effects of Concomitant Medications for Non-Alcoholic Steatohepatitis and Associated Comorbidities on Histological Improvements with Obeticholic Acid

Comprehensive NAFLD diagnosis based on a noninvasive metabolomic approach in a liquid biopsy

613 VALIDATION OF A DEFINITION AND GRADING SYSTEM FOR ACUTE ON CHRONIC LIVER FAILURE

P297 VITAMIN E ALTERS INTESTINAL MICROBIOME THROUGH DIFFERENTIAL CHANGES IN MUCOSAL AND FECAL MICROBIOTA IN MOUSE MODEL OF NONALCOHOLIC FATTY LIVER DISEASE (NALFD)

O044 : Distinct fecal and plasma bile acid metabolome of microbial origin characterizes human nonalcoholic fatty liver disease (NAFLD)

P0372 : Gideon: A retrospective analysis of prognostic factors for survival

191 EIGHT QUESTIONS OF THE PATIENT-REPORTED SICKNESS IMPACT PROFILE CAN EFFECTIVELY SCREEN FOR MINIMAL HEPATIC ENCEPHALOPATHY

148 PROTON PUMP INHIBITOR USE IS ASSOCIATED WITH THE DEVELOPMENT OF A BROAD RANGE OF INFECTIONS IN CIRRHOSIS

792 48 WEEKS OF PEGINTERFERON alfa-2a/RIBAVIRIN IMPROVES SVR24 AND DECREASES RELAPSE ACROSS HCV GENOTYPE 2/3 PATIENT SUBGROUPS NOT ACHIEVING A RAPID VIROLOGICAL RESPONSE: N-CORE STUDY

109 GIDEON (GLOBAL INVESTIGATION OF THERAPEUTIC DECISIONS IN HEPATOCELLULAR CARCINOMA AND OF ITS TREATMENT WITH SORAFENIB) SECOND INTERIM ANALYSIS: CLINICAL FINDINGS IN CHILD-PUGH B SCORE SUBGROUPS

150 SEVERITY OF CHRONIC COGNITIVE IMPAIRMENT IN CIRRHOSIS INCREASES WITH NUMBER OF EPISODES OF OVERT HEPATIC ENCEPHALOPATHY

Suchergebnisse filtern